Buscador de publicacions

Publicacions

  • Molnar C, Mora J and Gonzalez C.

    A Drosophila Study Model for EWS::FLI1-Induced Molecular Pathways.

    Methods In Molecular Biology (clifton, N.J.) . 3084: 395-415.

    [doi:10.1007/978-1-0716-5587-0_25]

  • Velázquez D, Molnar C, Reina J, Mora J and Gonzalez C.

    Ancient and animal-specific regulatory modes of EWS::FLI1 revealed by a minimal yeast model

    PNAS Nexus . 5(10): .

    [doi:10.1093/pnasnexus/pgag329]

  • Molnar C, Reina J, Mora J and Gonzalez C.

    The Drosophila FET ortholog Cabeza is an essential cofactor for ETV4-mediated activation of GGAA microsatellite neoenhancers

    G3-Genes Genomes Genetics . : .

    [doi:10.1093/g3journal/jkag265]

  • Balaguer-Lluna L, Resa-Parés C, Brstilo L, Gómez-Caballero A, Baulenas-Farrés M, Mohr J, Hu Y, Aschero MR, Rodríguez A, Botteri G, Rodriguez E, Li-Chen L, Mañogil R, Marino F, Martinez N, Ruano A, García-Pelayo Á, Giron A, Mora J, Lavarino C, Sánchez-Navarro M, Teixidó M, Ormazabal-Herrero A, Artuch-Iriberri R, Unceta N, Schaiquevich P and Carcaboso AM.

    CNS distribution and preclinical activity of the PI3K/AKT inhibitors inavolisib and ipatasertib in pediatric-type diffuse high-grade gliomas

    CANCER CHEMOTHERAPY AND PHARMACOLOGY . 96(1): .

    [doi:10.1007/s00280-026-04950-5]

  • Bruno A, Alvarez-Diduk R, Lara P, Maroli G, Cristina Larrosa Espinosa, López-Miralles S, Mora J, Rodriguez-Hernandez CJ and Merkoçi A.

    Quantum-Capacitance Biosensing Enables Real-Time Monitoring of Naxitamab for Therapeutic Response Stratification in Neuroblastoma

    Small Science . 6(8): .

    [doi:10.1002/smsc.70349]

  • Mora J, Howard S, Moreira DC, Chinnaswami G, Epelman S, Allen C and Chantada G.

    Scaling-Up Research in Childhood Cancer in Low- and Middle-Income Countries

    PEDIATRIC BLOOD & CANCER . 73(6): . Nº de cites: 1

    [doi:10.1002/1545-5017.70254]

  • Santa-María López V, Felip-Badia A, Marina Caballero Bellón, Sanchez-Sierra N, Castañeda-Heredia A, Garraus-Oneca M, Gorostegui M, Simão-Rafael M, Muñoz JP, Pérez-Somarriba M, Mañe S, Planells MC, Pérez-Jaume S and Mora J.

    Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio-Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse

    PEDIATRIC BLOOD & CANCER . 73(4): .

    [doi:10.1002/1545-5017.70105]

  • Schneider B, Redwanz C, Celis-Passini V, Esperanza-Cebollada E, Montesdeoca S, Salaverria I, Planas-Roman S, Conde N, Camós-Guijosa M, Arnau R, Lopez-Guillermo A, Maletzki C, Jou-Munoz C, Erbersdobler A, Shokraie O, Meyer-Bahlburg A, Ballmann M, Mora J, ELENA CAMPO, Classen CF and Cardesa-Salzmann TM.

    miRNA profiling in pediatric and young adult Burkitt leukemia and lymphoma

    VIRCHOWS ARCHIV . : 941-951.

    [doi:10.1007/s00428-026-04426-0]

  • Dela Cruz FS, Stewart EA, Surdez D, Daley JD, Soragni A, Tomazou EM, Alvarez-Perez J, Feinberg TY, Amatruda JF, Ganapathi SS, Ohm JE, Heske CM, Cohen-Gogo S, Pesic D, Nash JO, Shlien A, Roundhill EA, Burchill SA, Crompton BD, Lawlor ER, Loeb DM, Delattre O, Mora J, Scotlandi K, Reed DR, Grohar PJ, Grünewald TGP, Kovar H and Bailey KM.

    Advancing Preclinical Biology for Ewing Sarcoma: An International Effort

    MOLECULAR CANCER THERAPEUTICS . 25(1): 48-70. Nº de cites: 6

    [doi:10.1158/1535-7163.MCT-25-0428]

  • Rubio-San-Simón A, Marshall LV, Doz F, Mora J, Bielamowicz K, Corradini N, Langevin AM, Narendran A, Smith AA, Zwaan CM, Gho D, Cardenas A, Fowler S, Guizani C, Breton V, Wulff B, Bernardi R, Trippett T and Campbell-Hewson Q.

    Idasanutlin in Combination with Chemotherapy or Venetoclax in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors (iMATRIX Idasa): Results of a Phase I/II, Multicenter, Multi-arm Study

    Targeted Oncology . 21(1): 87-102. Nº de cites: 3

    [doi:10.1007/s11523-025-01186-w]